This monoshot contains 120 mg of sodium hyaluronate from ultra-pure, high molecular weight, biofermentated HA
This viscosupplement is designed to be highly cohesive, giving the “cushion effect”. Its highly cohesive...
This viscosupplement is designed to give a DUAL rheological property. It is perfectly balanced to be both cohesive and...
This viscosupplement is designed to be dispersive, providing a high coating power. Its dispersive rheological property will...
ETTSONS COMPANY: a French company founded end of 2013 in Annecy.
Walter Langiewicz, Founder and President.
ETTSONS ACTIVITY: on the basis of strong partnership, our company is fully dedicated in developing, manufacturing and marketing (HA) Hyaluronic Acid injectable devices.
ETTSONS RESSOURCES: working closely with experts who have been involved in Hyaluronic Acid injectable devices for more than 15 years.
ETTSONS CORE COMPETENCY: As HA specialists, ETTSONS and its partners have built a strong experience and Know-How in HA products by:
ETTSONS PHILOSOPHY: our main goal is the constant search for Safety, High Quality and Efficacy which constitute the fundamentals of our philosophy. A way of working for our PRODUCTS & SERVICE to our customers and patients; Always based on partnership.
ETTSONS is pleased to officially announce the launch of its MONOSHOT = SOLO 120 120 mg of pure HA in 1 single injection of 4.8 ML Designed to treat knee OA